Leaflet MAASOL 1.75mg/FLACON kit for radiopharmaceutical preparations for injectable suspension

Product code:
W58782001
Quantity:
5
Indicated for:
diagnostic imaging
Route of administration:
injectable
Substance:
macroaggregates of human albumin (contrast agent)
ATC
V09EB01 — Various | Respiratory system | Technetium (99mtc), particles for injection

Precautions:

Anaphylaxis

Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring

Additional monitoring

This medicine is subject to additional monitoring.

Macroaggregates of human albumin are used in medical imaging, particularly in lung scintigraphy, to assess pulmonary perfusion. These are composed of human albumin particles labeled with a radioactive marker.

The medication is administered intravenously and allows visualization of blood flow in the lungs using nuclear imaging techniques. It is commonly used for diagnosing pulmonary embolism or other lung conditions.

Adverse effects are rare but may include allergic reactions, nausea, or dizziness. Administration must be performed under the supervision of a nuclear medicine specialist.

Macroaggregates of human albumin are not recommended for patients with hypersensitivity to albumin or other components of the medication, as well as those with severe pulmonary hypertension.

General data about MAASOL 1.75mg/FLACON

Substance:
macroaggregates of human albumin
Date of latest medicines list:
01-11-2021
Product code:
W58782001
Concentration:
1.75mg / vial
Pharmaceutical form:
kit for radiopharmaceutical preparations for injectable suspension
Quantity:
5
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
GIPHARMA S.R.L. - ITALIA
Holder:
GE HEALTHCARE S.R.L. - ITALIA
Number:
4753/2012/01
Shelf life:
2 years-after packing for marketing, after reconstitution - 6h